Canada Opens Access for Psilocybin and MDMA Therapy
Cannabis Law Report
FEBRUARY 24, 2022
Thus, providing a new pathway for patients to access psychedelic treatment, and another example of the medicinal approach to psychedelic legalization. Each request is decided on a patient-by-patient basis and approval is usually only given to drugs with successful phase II or phase II clinical trials.
Let's personalize your content